Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma

As one of the most common malignant tumors worldwide, hepatocellular carcinoma (HCC) is known for its poor prognosis due to diagnosis only in advanced stages. Nearly 50% of the patients with the first diagnosis of HCC die within a year. Currently, the advancements in the integration of omics informa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Biol Sci
Autori principali: Wu, Xiaolin, Li, Jiahui, Gassa, Asmae, Buchner, Denise, Alakus, Hakan, Dong, Qiongzhu, Ren, Ning, Liu, Ming, Odenthal, Margarete, Stippel, Dirk, Bruns, Christiane, Zhao, Yue, Wahba, Roger
Natura: Artigo
Lingua:Inglês
Pubblicazione: Ivyspring International Publisher 2020
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7097921/
https://ncbi.nlm.nih.gov/pubmed/32226301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.44024
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi